1. Home
  2. AREN vs SLN Comparison

AREN vs SLN Comparison

Compare AREN & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AREN
  • SLN
  • Stock Information
  • Founded
  • AREN 2016
  • SLN 1994
  • Country
  • AREN United States
  • SLN United Kingdom
  • Employees
  • AREN N/A
  • SLN N/A
  • Industry
  • AREN Medical/Dental Instruments
  • SLN Biotechnology: Pharmaceutical Preparations
  • Sector
  • AREN Health Care
  • SLN Health Care
  • Exchange
  • AREN Nasdaq
  • SLN Nasdaq
  • Market Cap
  • AREN 305.8M
  • SLN 299.4M
  • IPO Year
  • AREN N/A
  • SLN N/A
  • Fundamental
  • Price
  • AREN $5.90
  • SLN $4.81
  • Analyst Decision
  • AREN Strong Buy
  • SLN Buy
  • Analyst Count
  • AREN 1
  • SLN 5
  • Target Price
  • AREN $12.00
  • SLN $32.60
  • AVG Volume (30 Days)
  • AREN 243.8K
  • SLN 61.8K
  • Earning Date
  • AREN 08-14-2025
  • SLN 08-07-2025
  • Dividend Yield
  • AREN N/A
  • SLN N/A
  • EPS Growth
  • AREN N/A
  • SLN N/A
  • EPS
  • AREN 2.74
  • SLN N/A
  • Revenue
  • AREN $146,610,000.00
  • SLN $27,169,000.00
  • Revenue This Year
  • AREN $29.48
  • SLN N/A
  • Revenue Next Year
  • AREN $11.72
  • SLN N/A
  • P/E Ratio
  • AREN $9.36
  • SLN N/A
  • Revenue Growth
  • AREN 6.81
  • SLN 22.28
  • 52 Week Low
  • AREN $0.56
  • SLN $1.97
  • 52 Week High
  • AREN $10.05
  • SLN $20.48
  • Technical
  • Relative Strength Index (RSI)
  • AREN 41.23
  • SLN 34.88
  • Support Level
  • AREN $6.09
  • SLN $4.91
  • Resistance Level
  • AREN $7.00
  • SLN $5.34
  • Average True Range (ATR)
  • AREN 0.64
  • SLN 0.48
  • MACD
  • AREN -0.12
  • SLN -0.05
  • Stochastic Oscillator
  • AREN 1.52
  • SLN 0.71

About AREN The Arena Group Holdings Inc.

The Arena Group Holdings Inc is a tech-powered media company that fuses technology, iconic brands, and marketing to deliver vibrant content and experiences that reach million users each month. The company creates robust digital destinations that delight consumers with powerful journalism, news about things such as favorite sports teams, advice on investing, the inside scoop on personal finance, and the latest on lifestyle essentials. The Company operates in one reportable segment which focuses on a publishing platform. The company generates revenue from Digital and Print, where the majority is generated from Digital. The company owns and operates TheStreet, The Spun, Parade, and Men's Journal and powers more than 320 independent Publisher Partners.

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

Share on Social Networks: